open access
Relationships between hormonal parameters, body fat distribution and bone mineral density in women with psychogenic functional hypothalamic amenorrhea
, 23, 2
Affiliations- Department of Diabetology and Internal Medicine, Pomeranian Medical University, Poland
- Department of Endocrinology, Metabolic and Internal Diseases, Pomeranian Medical University, Szczecin, Poland
- Department of Gynecology and Obstetrics, Klinikum Frankfurt (Oder), Frankfurt (Oder), Germany
open access
Abstract
Objectives: Available evidence implies that unfavorable changes in the distribution of adipose tissue resulting from hormonal imbalance associated with ovarian insufficiency might influence bone mineral density (BMD). The purpose of our study was to verify if volumes of visceral (VAT), female (FAT) and android (AAT) body fat as determined by densitometry determined influence BMD in women with functional menstrual disorders, and if these correlates some endocrine factors.
Material and methods: We examined 293 women (mean age 26.7 ± 4.4 years) who have had psychogenic type of functional hypothalamic secondary amenorrhea for at least three months (mean 5.82 ± 0.94). A variety of hormonal tests, determination of BMD and both distribution and volume of adipose tissue were performed.
Results: Volume of adipose tissue in all analyzed body regions indicated a positive correlation with BMD in lumbar spine (VAT: R = 0.277, FAT: R = 0.345, AAT: R = 0.336) and entire skeleton (VAT: R = 0.453, FAT: R = 0.527, AAT: R = 0.529). BMD in both the lumbar spine and entire skeleton had positive correlation with body mass index (R = 0.380 and R = 0.599, respectively) and free androgen index values (R = 0.150 and R = 0.279). It showed a negative correlation with sex hormone-binding globulin (R = –0.191 and R = –0.326). We did not find a parameter that could be an independent predictor of BMD.
Conclusions: Distribution of body fat is only one of numerous determinants of BMD in women with functional menstrual disorders and should not be treated as the only predictor for bone mass deficiency. Determination of adipose tissue distribution in these patients has probably minor clinical impact.
Abstract
Objectives: Available evidence implies that unfavorable changes in the distribution of adipose tissue resulting from hormonal imbalance associated with ovarian insufficiency might influence bone mineral density (BMD). The purpose of our study was to verify if volumes of visceral (VAT), female (FAT) and android (AAT) body fat as determined by densitometry determined influence BMD in women with functional menstrual disorders, and if these correlates some endocrine factors.
Material and methods: We examined 293 women (mean age 26.7 ± 4.4 years) who have had psychogenic type of functional hypothalamic secondary amenorrhea for at least three months (mean 5.82 ± 0.94). A variety of hormonal tests, determination of BMD and both distribution and volume of adipose tissue were performed.
Results: Volume of adipose tissue in all analyzed body regions indicated a positive correlation with BMD in lumbar spine (VAT: R = 0.277, FAT: R = 0.345, AAT: R = 0.336) and entire skeleton (VAT: R = 0.453, FAT: R = 0.527, AAT: R = 0.529). BMD in both the lumbar spine and entire skeleton had positive correlation with body mass index (R = 0.380 and R = 0.599, respectively) and free androgen index values (R = 0.150 and R = 0.279). It showed a negative correlation with sex hormone-binding globulin (R = –0.191 and R = –0.326). We did not find a parameter that could be an independent predictor of BMD.
Conclusions: Distribution of body fat is only one of numerous determinants of BMD in women with functional menstrual disorders and should not be treated as the only predictor for bone mass deficiency. Determination of adipose tissue distribution in these patients has probably minor clinical impact.
Keywords
estrogens; visceral fat; subcutaneous fat; amenorrhea; mineralization
About this articleTitle
Relationships between hormonal parameters, body fat distribution and bone mineral density in women with psychogenic functional hypothalamic amenorrhea
Journal
Issue
Article type
Research paper
Pages
753-759
Published online
2021-04-22
Page views
6781
Article views/downloads
966
DOI
Pubmed
Bibliographic record
Ginekol Pol 2021;92(11):753-759.
Keywords
estrogens
visceral fat
subcutaneous fat
amenorrhea
mineralization
Authors
Justyna Syrenicz
Mariola Krzyscin
Elzbieta Sowinska-Przepiera
References (27)- Gordon CM. Functional hypothalamic amenorrhea. N Engl J Med. 2010; 363(4): 365–371.
- Joy EA, Campbell D. Stress fractures in the female athlete. Curr Sports Med Rep. 2005; 4(6): 323–328.
- Riggs BL. The mechanisms of estrogen regulation of bone resorption. J Clin Invest. 2000; 106(10): 1203–1204.
- Valentino R, Savastano S, Tommaselli AP, et al. The influence of intense ballet training on trabecular bone mass, hormone status, and gonadotropin structure in young women. J Clin Endocrinol Metab. 2001; 86(10): 4674–4678.
- Vanderschueren D, Vandenput L, Boonen S, et al. Androgens and bone. Endocr Rev. 2004; 25(3): 389–425.
- Siemińska L. Adipose tissue. Pathophysiology, distribution, sex differences and the role in inflammation and cancerogenesis. Endokrynol Pol. 2007; 58(4): 330–342.
- Deere K, Sayers A, Viljakainen HT, et al. Distinct relationships of intramuscular and subcutaneous fat with cortical bone: findings from a cross-sectional study of young adult males and females. J Clin Endocrinol Metab. 2013; 98(6): E1041–E1049.
- Gilsanz V, Chalfant J, Mo AO, et al. Reciprocal relations of subcutaneous and visceral fat to bone structure and strength. J Clin Endocrinol Metab. 2009; 94(9): 3387–3393.
- Bredella MA, Torriani M, Ghomi RH, et al. Vertebral bone marrow fat is positively associated with visceral fat and inversely associated with IGF-1 in obese women. Obesity (Silver Spring). 2011; 19(1): 49–53.
- Russell M, Mendes N, Miller KK, et al. Visceral fat is a negative predictor of bone density measures in obese adolescent girls. J Clin Endocrinol Metab. 2010; 95(3): 1247–1255.
- Singhal V, Maffazioli GDN, Cano Sokoloff N, et al. Regional fat depots and their relationship to bone density and microarchitecture in young oligo-amenorrheic athletes. Bone. 2015; 77: 83–90.
- Genazzani AD, Ricchieri F, Lanzoni C, et al. Diagnostic and therapeutic approach to hypothalamic amenorrhea. Ann N Y Acad Sci. 2006; 1092: 103–113.
- Sowińska-Przepiera E, Andrysiak-Mamos E, Jarząbek-Bielecka G, et al. Functional hypothalamic amenorrhea – diagnostic challenges, monitoring and treatment. Endokrynologia Polska. 2015; 66(3): 252–268.
- Pasquali R. Obesity and androgens: facts and perspectives. Fertil Steril. 2006; 85(5): 1319–1340.
- Pasquali R, Casimirri F, Platè L, et al. Characterization of obese women with reduced sex hormone-binding globulin concentrations. Horm Metab Res. 1990; 22(5): 303–306.
- Tchernof A, Després JP. Sex steroid hormones, sex hormone-binding globulin, and obesity in men and women. Horm Metab Res. 2000; 32(11-12): 526–536.
- Kirschner MA, Samojlik E, Drejka M, et al. Androgen-estrogen metabolism in women with upper body versus lower body obesity. J Clin Endocrinol Metab. 1990; 70(2): 473–479.
- Iacobellis G, Ribaudo MC, Zappaterreno A, et al. Relationship of thyroid function with body mass index, leptin, insulin sensitivity and adiponectin in euthyroid obese women. Clin Endocrinol (Oxf). 2005; 62(4): 487–491.
- Nannipieri M, Cecchetti F, Anselmino M, et al. Expression of thyrotropin and thyroid hormone receptors in adipose tissue of patients with morbid obesity and/or type 2 diabetes: effects of weight loss. Int J Obes (Lond). 2009; 33(9): 1001–1006.
- Radetti G, Kleon W, Buzi F, et al. Thyroid function and structure are affected in childhood obesity. J Clin Endocrinol Metab. 2008; 93(12): 4749–4754.
- Pala NA, Laway BA, Misgar RA, et al. Profile of leptin, adiponectin, and body fat in patients with hyperprolactinemia: Response to treatment with cabergoline. Indian J Endocrinol Metab. 2016; 20(2): 177–181.
- Kopelman PG, Weaver JU, Noonan K, et al. Impaired hypothalamic control of prolactin secretion in massive obesity. Lancet. 1979; 313(8119): 747–750.
- Weaver JU, Noonan K, Kopelman PG, et al. Impaired prolactin secretion and body fat distribution in obesity. Clin Endocrinol (Oxf). 1990; 32(5): 641–646.
- Bjørnerem A, Emaus N, Berntsen GKR, et al. Circulating sex steroids, sex hormone-binding globulin, and longitudinal changes in forearm bone mineral density in postmenopausal women and men: the Tromsø study. Calcif Tissue Int. 2007; 81(2): 65–72.
- Ooms ME, Lips P, Roos JC, et al. Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women. J Bone Miner Res. 1995; 10(8): 1177–1184.
- Rapuri PB, Gallagher JC, Haynatzki G. Endogenous levels of serum estradiol and sex hormone binding globulin determine bone mineral density, bone remodeling, the rate of bone loss, and response to treatment with estrogen in elderly women. J Clin Endocrinol Metab. 2004; 89(10): 4954–4962.
- Isales CM, Zaidi M, Blair HC. ACTH is a novel regulator of bone mass. Ann N Y Acad Sci. 2010; 1192: 110–116.
